Canada Life’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-9,077
| Closed | -$54K | – | 2785 |
|
|
2019
Q4 | $54K | Buy |
+9,077
| New | +$52.5K | ﹤0.01% | 2242 |
|
|
2019
Q3 | – | Sell |
-8,721
| Closed | -$23K | – | 2677 |
|
|
2019
Q2 | $23K | Hold |
8,721
| – | – | ﹤0.01% | 2576 |
|
|
2019
Q1 | $26K | Hold |
8,721
| – | – | ﹤0.01% | 2351 |
|
|
2018
Q4 | $13K | Hold |
8,721
| – | – | ﹤0.01% | 2571 |
|
|
2018
Q3 | $32K | Hold |
8,721
| – | – | ﹤0.01% | 2469 |
|
|
2018
Q2 | $25K | Hold |
8,721
| – | – | ﹤0.01% | 2502 |
|
|
2018
Q1 | $32K | Hold |
8,721
| – | – | ﹤0.01% | 2451 |
|
|
2017
Q4 | $25K | Hold |
8,721
| – | – | ﹤0.01% | 2481 |
|
|
2017
Q3 | $38K | Hold |
8,721
| – | – | ﹤0.01% | 2404 |
|
|
2017
Q2 | $40K | Hold |
8,721
| – | – | ﹤0.01% | 2384 |
|
|
2017
Q1 | $37K | Hold |
8,721
| – | – | ﹤0.01% | 2375 |
|
|
2016
Q4 | $36K | Hold |
8,721
| – | – | ﹤0.01% | 2400 |
|
|
2016
Q3 | $70K | Hold |
8,721
| – | – | ﹤0.01% | 2260 |
|
|
2016
Q2 | $68K | Hold |
8,721
| – | – | ﹤0.01% | 2234 |
|
|
2016
Q1 | $67K | Hold |
8,721
| – | – | ﹤0.01% | 2011 |
|
|
2015
Q4 | $94K | Hold |
8,721
| – | – | ﹤0.01% | 1803 |
|
|
2015
Q3 | $60K | Hold |
8,721
| – | – | ﹤0.01% | 2007 |
|
|
2015
Q2 | $77K | Hold |
8,721
| – | – | ﹤0.01% | 2028 |
|
|
2015
Q1 | $86K | Hold |
8,721
| – | – | ﹤0.01% | 1888 |
|
|
2014
Q4 | $107K | Buy |
+8,721
| New | +$107K | ﹤0.01% | 1705 |
|
Canada Life's ACHN Position: Q1 2020 in Review
Canada Life sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 9,077 shares — an estimated $54K sold.
Canada Life first reported a position in ACHN in Q4 2014 and held it in 20 quarters. The position peaked at $107K in Q4 2014. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Canada Life reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Canada Life sold 9,077 Achillion Pharmaceuticals shares in Q1 2020, an estimated $54K.
- Canada Life first reported a position in Achillion Pharmaceuticals in Q4 2014 and held it in 20 quarters.
- Canada Life's Achillion Pharmaceuticals position peaked at $107K in Q4 2014.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Canada Life's 13F filing for Q1 2020, filed 14 May 2020.